Primary Health Properties PLC
27 May 2005
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
Primary Health Properties PLC
2. Name of director
James Daryl Hambro
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest
Non-beneficial interest
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified)
J O HAMBRO CAPITAL MANAGEMENT LIMITED
5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)
Director of J O HAMBRO CAPITAL MANAGEMENT LIMITED
6. Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
7. Number of shares / amount of stock acquired
8. Percentage of issued class
9. Number of shares/amount of stock disposed
476,776
10. Percentage of issued class
11. Class of security
Ordinary shares of 50 pence each
12. Price per share
25,000 @ 3.00
25,000 @ 3.00
300,000 @ 2.975
126,667 @2.88
13. Date of transaction
25 May 2005 Disposal completed 3 sales completed during the month of April
2005
14. Date company informed
27 May 2005
15. Total holding following this notification
0 non beneficial 10,000 beneficial
16. Total percentage holding of issued class following this notification
Nil non beneficial
If a director has been granted options by the company please complete the
following boxes.
17. Date of grant
18. Period during which or date on which exercisable
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved: class, number
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise
22. Total number of shares or debentures over which options held following this
notification
23. Any additional information
24. Name of contact and telephone number for queries
RACHEL BUTLIN 0207 747 5680
25. Name and signature of authorised company official responsible for making
this notification
RACHEL BUTLIN COMPANY SECRETARY FOR AND ON BEHALF OF J O HAMBRO CAPITAL
MANAGEMENT LIMITED AS COMPANY SECRETARY of
Primary Health Properties PLC
Date of Notification
27 May 2005
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.